About

​​

Emily Lai-Ho MacLean is a Canadian Institutes of Health Research postdoctoral fellow at the Centre of Research Excellence in Tuberculosis Control and University of Sydney NHMRC Clinical Trials Centre. Additionally, Emily serves as Lead of the New Diagnostic Working Group’s Biomarkers Taskforce of the Stop TB Partnership. She is interested in TB epidemiology as well as the evaluation and implementation of new tuberculosis tests, particularly among under-researched groups such as people with extrapulmonary tuberculosis, people with drug-resistant tuberculosis, and young people. She also works on refining and applying methods to improve the quality of the tuberculosis diagnostics evidence base.

​

Academic Profile